Clinic

EQS-News: ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease

Retrieved on: 
Wednesday, April 10, 2024
Cell, Bone marrow, Disease, Transplant, Risk, Clinic, Patient, Gastrointestinal tract, Mortality, Haematopoietic system, Leukemia, Quality of life, Graft-versus-host disease, Clinical trial, Skin, Safety, CSO, Liver, Acute leukemia, Vaccine

GvHD is a severe and potentially life-threatening complication that can arise after an allogeneic haematopoietic stem cell transplantation and affects about 50 % of recipients.

Key Points: 
  • GvHD is a severe and potentially life-threatening complication that can arise after an allogeneic haematopoietic stem cell transplantation and affects about 50 % of recipients.
  • GvHD occurs when the stem cell donor’s T cells attack the patient’s tissues, leading to a range of symptoms that can affect the skin, gastrointestinal tract, and liver.
  • Prof. Dr. Andrea Tüttenberg, CEO of ActiTrexx, said: “GvHD can lead to life-long symptoms for the patient and is a major cause for the high mortality rate of blood stem cell transplantation.
  • Ten patients who have recently received a blood stem cell transplantation as treatment for leukemia will receive a single treatment with Actileucel.

NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US

Retrieved on: 
Friday, April 5, 2024
Head, Roche, MIT Technology Review, IP, FCCP, Clinic, Seed, Consciousness, Partnership, Novartis, SAN, DNA, Aneurysm, Critical care, Stanford School, Cedars-Sinai Medical Center, Lawyer, Harvard Medical School, DSS, University, MD, Hospital, FDA, Apnea, Brain, ALS, MIT, Neocortex, Biomarker, Bird, Doctor of Philosophy, Human, Brain tumor, BCIS, Silicon, Patent, VCS, Division

The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.

Key Points: 
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • A joint abstract by Dr. Low and Dr. Hawking featuring Dr. Hawking’s brain patterns analyzed by NeuroVigil’s technology was released as early as 2012.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.

CORRECTION -- NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US

Retrieved on: 
Friday, April 5, 2024
Head, Roche, MIT Technology Review, IP, FCCP, Clinic, Seed, Consciousness, Partnership, Novartis, SAN, DNA, Aneurysm, Critical care, Stanford School, Cedars-Sinai Medical Center, Lawyer, Harvard Medical School, DSS, University, MD, Hospital, FDA, Apnea, Brain, ALS, MIT, Neocortex, Biomarker, Bird, Doctor of Philosophy, Human, Brain tumor, BCIS, Patent, VCS, Division

“Who needs implants when you have the real deal?” said Dr. Philip Low, PhD, NeuroVigil’s Chairman, Chief Executive and Technology Officer, Founder and Supermajority Owner.

Key Points: 
  • “Who needs implants when you have the real deal?” said Dr. Philip Low, PhD, NeuroVigil’s Chairman, Chief Executive and Technology Officer, Founder and Supermajority Owner.
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.

NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US

Retrieved on: 
Friday, April 5, 2024
Head, Roche, MIT Technology Review, IP, FCCP, Clinic, Seed, Consciousness, Partnership, Novartis, SAN, DNA, Aneurysm, Critical care, Stanford School, Cedars-Sinai Medical Center, Lawyer, Harvard Medical School, DSS, University, MD, Hospital, FDA, Apnea, Brain, ALS, MIT, Neocortex, Biomarker, Bird, Doctor of Philosophy, Human, Brain tumor, BCIS, Silicon, Patent, VCS, Division

The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.

Key Points: 
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • A joint abstract by Dr. Low and Dr. Hawking featuring Dr. Hawking’s brain patterns analyzed by NeuroVigil’s technology was released as early as 2012.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.

NETSCOUT Research Finds 97% of Enterprises Experienced Major UCaaS-Related Outages in 2023

Retrieved on: 
Tuesday, April 9, 2024
Apps, Applications, Technology, Mobile, Wireless, Telecommunications, Software, Networks, Internet, Artificial Intelligence, VoIP, Organization, PDF, Software as a service, Research, NTCT, Overalls, Clinic, Denial-of-service attack, Business performance management, Unified communications, Online shopping

Forty-seven percent of enterprises with annual revenue over $10 billion estimated losses of $100,000 to one million dollars or more.

Key Points: 
  • Forty-seven percent of enterprises with annual revenue over $10 billion estimated losses of $100,000 to one million dollars or more.
  • 51% of enterprises experienced at least four major UCaaS-related outages in the past year.
  • “When essential platforms experience widespread and persistent outages, the disruption interrupts critical business operations and can lead to substantial financial losses,” said Michael Szabados, chief operating officer, NETSCOUT.
  • Visit our website to download a PDF of the research findings or to learn more about our UCaaS solutions .

Virtual Second Opinions Save Over $8,700 Per Patient, New Analysis Finds

Retrieved on: 
Tuesday, March 26, 2024
General Health, Health, Practice Management, Telemedicine, Virtual Medicine, Managed Care, Diagnosis, Clinic, Disability, Quality of life, Stoma, Life, Vital statistics, VSO, Cleveland Clinic, Death, Hospital

A new quantitative case analysis from The Clinic by Cleveland Clinic , a leading provider of virtual second opinions (VSOs), reveals that its second opinions produce an average savings of $8,705 per patient.

Key Points: 
  • A new quantitative case analysis from The Clinic by Cleveland Clinic , a leading provider of virtual second opinions (VSOs), reveals that its second opinions produce an average savings of $8,705 per patient.
  • The analysis of The Clinic’s VSOs demonstrates that second opinions from expert specialists can prevent misdiagnoses and overtreatment.
  • Key findings from the analysis include:
    In addition to savings, the analysis uncovered numerous examples of the dramatic impact of VSOs on patients’ peace of mind and quality of life.
  • Even if major surgery is indeed right for you, a virtual second opinion provides confidence that you’re on the right path.

New International Study Reports Extension of the Donor Lung Transplantation Window

Retrieved on: 
Tuesday, March 12, 2024
FDA, Surgery, Medical Devices, Hospitals, Health, Clinic, Temperature, UZ Leuven, Transplant, Massachusetts General Hospital, Assistant, Motol University Hospital, Risk, Patient, Transport, Lung transplantation, Surgeon, Thorax, Ice, Dentistry

This milestone publication lays a strong foundation for future clinical applications in organ preservation and transplantation.

Key Points: 
  • This milestone publication lays a strong foundation for future clinical applications in organ preservation and transplantation.
  • For example, presenting a means to better accommodate longer transportation times, overnight bridging, or optimizing case scheduling during the day.
  • During the six-month study period, the LUNGguard® Donor Lung Preservation System was utilized to preserve donor lungs for over 15 hours in 13 separate instances.
  • Longer ischemic times increase the risk of primary graft dysfunction, a serious complication that can occur after lung transplantation.

Athletico Physical Therapy Opens in Grand Blanc, Michigan

Retrieved on: 
Thursday, March 28, 2024
Athletico Physical Therapy, Diagnosis, Clinic, Health, DPT, Dizziness, Therapy, Communication, Risk, Headache, Patient, Motion, Insurance, Life, Kroger, Dry needling, Pain, Starbucks, Rehabilitation, Nursing

GRAND BLANC, Mich., March 28, 2024 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Grand Blanc, Michigan, located across from Kroger and next to Starbucks on S. Saginaw Rd. This location offers convenient hours, including early morning, late evening and Saturday appointments, and does not require a referral or prescription to start treatment. To learn more, or to schedule a free assessment, visit www.athletico.com/GrandBlanc.

Key Points: 
  • GRAND BLANC, Mich., March 28, 2024 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Grand Blanc, Michigan, located across from Kroger and next to Starbucks on S. Saginaw Rd.
  • "I'm looking forward to providing quality physical therapy services to patients in the wonderful community of Grand Blanc," said Brad Bond, PT, DPT, Clinic Manager of Athletico Grand Blanc.
  • "Physical therapy has many benefits for individuals experiencing pain, decreased range of motion, strength or balance issues, and anything that impairs the quality and function of their life.
  • Services available at Athletico Grand Blanc include:
    Physical therapy – Our physical therapists treat you to reduce pain, improve or restore mobility, and to help you remain at your optimal health without further risk of injury.

Accelecom Enhances Network Connectivity for UK HealthCare

Retrieved on: 
Tuesday, March 26, 2024
Clinic, Health, Data, UK HealthCare, Communication

LOUISVILLE, Ky., March 26, 2024 /PRNewswire/ -- Accelecom , a leading next-generation communication solutions provider announced today it's been selected by UK HealthCare to provide next-generation fiber connectivity into their strategic Data Centers and rural Clinics.

Key Points: 
  • LOUISVILLE, Ky., March 26, 2024 /PRNewswire/ -- Accelecom , a leading next-generation communication solutions provider announced today it's been selected by UK HealthCare to provide next-generation fiber connectivity into their strategic Data Centers and rural Clinics.
  • "Accelecom is honored to partner with UK HealthCare, a renowned institution dedicated to advancing healthcare and improving patient outcomes," said Brad Kilbey, CEO of Accelecom.
  • The deployment of Accelecom's next-generation fiber solutions at UK HealthCare underscores a commitment to innovation and excellence in healthcare technology.
  • By leveraging Accelecom's expertise and state-of-the-art infrastructure, UK HealthCare will benefit from increased network diversity, low-latency connectivity, and seamless data transmission critical for modern healthcare operations.

My Clinic Receives Healthcare Tech-Contact Excellence Award from IST Networks & Genesys

Retrieved on: 
Monday, March 25, 2024
Cloud, Clinic, Health, Organization, Motivation, IST, Partnership, Patient, Salesforce, Social media, Health care, Kingdom, Vision 2030, Patient satisfaction, Platinum, Human, Nursing

RIYADH, Saudi Arabia, March 25, 2024 /PRNewswire/ -- My Clinic, a leading healthcare provider in the Kingdom of Saudi Arabia, has been honored with the prestigious Healthcare Tech-Contact Excellence Award by IST Networks and Genesys.

Key Points: 
  • RIYADH, Saudi Arabia, March 25, 2024 /PRNewswire/ -- My Clinic, a leading healthcare provider in the Kingdom of Saudi Arabia, has been honored with the prestigious Healthcare Tech-Contact Excellence Award by IST Networks and Genesys.
  • As the Genesys partner of choice for implementing this innovative solution in healthcare, IST Networks, a platinum Genesys partner, has demonstrated its expertise in transforming patient care through technology.
  • My Clinic has implemented the Genesys Cloud along with an integration with Salesforce, featuring channels like voice, messaging, email, and social engagement.
  • "We are profoundly honored to receive the Healthcare Tech-Contact Excellence Award from IST Networks and Genesys, a recognition that reflects our unwavering commitment to revolutionizing patient care through technology.